Board approves preferential issue, subsidiary sale, director changes

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.0%Reaction day

₹6.73

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.0%+5.0% vs market

Software Products peers, median of 41sector-0.6%+4.6% vs sector

On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250 and 4.6 pts more than its Software Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.0-1.0+5.0-0.6+4.6

Next day

+9.2-1.5+10.8-0.9+10.1

+7.0-0.9+7.9-0.7+7.7

-1.6-0.3-1.4-1.3-0.3

-6.5+0.1-6.7-1.0-5.6

-11.1+0.7-11.8-1.3-9.8

-8.0+0.3-8.3-3.6-4.4

15d

-27.5+1.0-28.4-4.4-23.1

-33.9-2.4-31.5-5.1-28.8

—————

UpDownMarket · Nifty Microcap 250Sector · Software Products peers, median of 41Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nihar Info Global board approved issuing 11.7 lakh equity shares at Rs 10 to 12 non-promoters and 20 lakh convertible warrants to promoters (18 month exercise window). Approved sale of subsidiaries Life 108 Healthcare (51.43% stake for Rs 2.18 crore) and Beastbells Media (99% stake for Rs 2.20 lakh) to Director Vijaya Lakshmi Boda as a related party deal. New Independent Director Annapantula Seetarama Murthy appointed for 5 years; Ajit Kumar Nagrani retired on completing second term. AGM set for Sept 30, 2026.

Likely market impact

Equity dilution of about 10% plus potential 20% from warrants; promoter holding rises to 30% fully diluted. Subsidiary sale to director is a related party deal needing AGM approval.